Is Immunotherapy for All Types of Brain Tumors? Ask a Scientist скачать в хорошем качестве

Is Immunotherapy for All Types of Brain Tumors? Ask a Scientist

Dr. David Reardon of Dana-Farber Cancer Institute answers questions from our patient community about cancer immunotherapy for patients with brain tumors. For more, visit https://www.cancerresearch.org/patien... #AskAScientist #Immunotherapy Immunotherapy is being studied for many different types of brain cancer, typically the most common brain cancers, such as glioblastoma. With more experience, promise, and benefit in common types, scientists and clinicians can move into rarer brain cancers. David Reardon, M.D., serves as Clinical Director at Dana-Farber Cancer Institute's Center for Neuro-Oncology, is a Professor at Harvard Medical School and a member of the Cancer Research Institute’s Clinical Trial Network. Dr. Reardon discussed immunotherapy in connection to brain tumors (including glioblastoma) as part of Brain Tumor Awareness Month. This video series is made possible with generous support from Celldex Therapeutics. Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization that is dedicated to harnessing our immune system's power to control and potentially cure all cancers. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field's leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. Our Mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. https://www.cancerresearch.org